Your browser doesn't support javascript.
loading
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma.
Seidel, Philipp; Rubarth, Anne; Zodel, Kyra; Peighambari, Asin; Neumann, Felix; Federkiel, Yannick; Huang, Hsin; Hoefflin, Rouven; Adlesic, Mojca; Witt, Christian; Hoffmann, David J; Metzger, Patrick; Lindemann, Ralph K; Zenke, Frank T; Schell, Christoph; Boerries, Melanie; von Elverfeldt, Dominik; Reichardt, Wilfried; Follo, Marie; Albers, Joachim; Frew, Ian J.
Afiliação
  • Seidel P; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Rubarth A; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Zodel K; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Peighambari A; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Neumann F; Translational Innovation Platform Oncology and Immuno-Oncology, the Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Federkiel Y; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Huang H; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Hoefflin R; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Adlesic M; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Witt C; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Hoffmann DJ; Department of Internal Medicine I, Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Metzger P; Institute of Medical Bioinformatics and.
  • Lindemann RK; Translational Innovation Platform Oncology and Immuno-Oncology, the Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Zenke FT; Translational Innovation Platform Oncology and Immuno-Oncology, the Healthcare Business of Merck KGaA, Darmstadt, Germany.
  • Schell C; Institute for Surgical Pathology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
  • Boerries M; Institute of Medical Bioinformatics and.
  • von Elverfeldt D; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Freiburg, Freiburg, Germany.
  • Reichardt W; Comprehensive Cancer Center Freiburg (CCCF) and.
  • Follo M; Comprehensive Cancer Center Freiburg (CCCF) and.
  • Albers J; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Partner Site Freiburg, Freiburg, Germany.
  • Frew IJ; Medical Physics, Department of Radiology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
JCI Insight ; 7(24)2022 12 22.
Article em En | MEDLINE | ID: mdl-36413415
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: JCI Insight Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha